Eag1 Potassium Channels in Tumors
Author Information
Author(s): Bernhard Hemmerlein, Rüdiger M. Weseloh, Fernanda Mello de Queiroz, Hendrik Knötgen, Araceli Sánchez, María E. Rubio, Sabine Martin, Tessa Schliephacke, Marc Jenke, Heinz-Joachim Radzun, Walter Stühmer, Luis A. Pardo
Primary Institution: Georg-August University
Hypothesis
Eag1 potassium channels are overexpressed in various human tumors and may serve as a therapeutic target.
Conclusion
Eag1 is frequently overexpressed in tumors, suggesting it could be a promising target for cancer treatment.
Supporting Evidence
- Eag1 expression was detected in 80% of breast cancer samples.
- The study found Eag1 overexpression in various tumor types including prostate and colon cancers.
- Inhibition of Eag1 reduced tumor cell proliferation in vitro.
Takeaway
Eag1 is a special protein found in many tumors but not in normal tissues, which means it could help doctors treat cancer better.
Methodology
The study used real-time PCR and immunohistochemistry to analyze Eag1 expression in normal and tumor tissues.
Potential Biases
Potential bias in sample selection and the specificity of antibodies used for detection.
Limitations
The study may not account for all tumor types and the variability in Eag1 expression across different tissues.
Participant Demographics
The study included various tumor types from human biopsy specimens.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website